Literature DB >> 6198318

Childhood psychosis and monoamine metabolites in spinal fluid.

C Gillberg, L Svennerholm, C Hamilton-Hellberg.   

Abstract

Determination of monoamine metabolites was accomplished in the spinal fluid of 22 psychotic children and in 22 sex- and almost-age-matched "normal" controls. Also, specimens from groups of mentally retarded children and children with progressive encephalopathy or meningitis were used for comparison. The psychotic children showed raised levels of homovanillic acid. Thirteen children diagnosed as autistic by Rutter's criteria showed isolated increase of this metabolite. In the group of 9 children with other psychoses, both the level of homovanillic acid and that of 5-hydroxy-indoleacetic acid was raised. The comparison with the group of "simply" mentally retarded children and results within the psychotic group revealed that the increased concentration of monoamines was not attributable to mental retardation per se.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6198318     DOI: 10.1007/bf01531587

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  10 in total

Review 1.  Neurochemistry and child psychiatry.

Authors:  D J Cohen; J G Young
Journal:  J Am Acad Child Psychiatry       Date:  1977

2.  Blood serotonin in psychotic and brain damaged children.

Authors:  M Campbell; E Friedman; E DeVito; L Greenspan; P J Collins
Journal:  J Autism Child Schizophr       Date:  1974 Jan-Mar

3.  Increased blood serotonin and platelets in early infantile autism.

Authors:  E R Ritvo; A Yuwiler; E Geller; E M Ornitz; K Saeger; S Plotkin
Journal:  Arch Gen Psychiatry       Date:  1970-12

4.  Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity.

Authors:  G Sedvall; B Fyrö; B Gullberg; H Nybäck; F A Wiesel; B Wode-Helgodt
Journal:  Br J Psychiatry       Date:  1980-04       Impact factor: 9.319

5.  Overview of selected basic research in autism.

Authors:  L R Piggott
Journal:  J Autism Dev Disord       Date:  1979-06

6.  Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method.

Authors:  B Sandgárde; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

7.  Maternal age and infantile autism.

Authors:  C Gillberg
Journal:  J Autism Dev Disord       Date:  1980-09

8.  Estimation of monoamine and cyclic-AMP turnover and amino acid concentrations of spinal fluid in autistic children.

Authors:  B G Winsberg; J Sverd; S Castells; M Hurwic; J M Perel
Journal:  Neuropediatrics       Date:  1980-08       Impact factor: 1.947

Review 9.  Clinical neurochemistry of autism and associated disorders.

Authors:  J G Young; M E Kavanagh; G M Anderson; B A Shaywitz; D J Cohen
Journal:  J Autism Dev Disord       Date:  1982-06

10.  Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism.

Authors:  C R Lake; M G Ziegler; D L Murphy
Journal:  Arch Gen Psychiatry       Date:  1977-05
  10 in total
  14 in total

Review 1.  Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy.

Authors:  J K Buitelaar; S H Willemsen-Swinkels
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  Childhood psychosis and neurofibromatosis--more than a coincidence?

Authors:  C Gillberg; C Forsell
Journal:  J Autism Dev Disord       Date:  1984-03

3.  Investigation of whole blood and urine monoamines in autism.

Authors:  Josiane Hérault; Joëlle Martineau; Anne Perrot-Beaugerie; Jacqueline Jouve; Hervé Tournade; Catherine Barthelemy; Gilbert Lelord; Jean-Pierre Muh
Journal:  Eur Child Adolesc Psychiatry       Date:  1993-10       Impact factor: 4.785

Review 4.  Medication treatment in subjects with autistic spectrum disorders.

Authors:  J K Buitelaar; S H Willemsen-Swinkels
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 5.  Pharmacotherapy of pervasive developmental disorders in children and adolescents.

Authors:  Gabriele Masi
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

6.  Plasma and urinary levels of biopterin, neopterin, and related pterins and plasma levels of folate in infantile autism.

Authors:  I Eto; M D Bandy; C E Butterworth
Journal:  J Autism Dev Disord       Date:  1992-06

7.  Growth hormone response to L-dopa and clonidine in autistic children.

Authors:  G M Realmuto; J B Jensen; E Reeve; B D Garfinkel
Journal:  J Autism Dev Disord       Date:  1990-12

8.  Amisulpride versus bromocriptine in infantile autism: a controlled crossover comparative study of two drugs with opposite effects on dopaminergic function.

Authors:  S Dollfus; M Petit; J F Menard; P Lesieur
Journal:  J Autism Dev Disord       Date:  1992-03

9.  Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children.

Authors:  J M Launay; C Bursztejn; P Ferrari; C Dreux; A Braconnier; E Zarifian; S Lancrenon; J Fermanian
Journal:  J Autism Dev Disord       Date:  1987-09

10.  Urinary free and conjugated catecholamines and metabolites in autistic children.

Authors:  C Barthelemy; N Bruneau; J M Cottet-Eymard; J Domenech-Jouve; B Garreau; G Lelord; J P Muh; L Peyrin
Journal:  J Autism Dev Disord       Date:  1988-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.